Long-Term Efficacy and Safety of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Insights from RAMP 201

Long-term safety and efficacy data for Avutometinib + Defactinib in recurrent low-grade serous ovarian cancer, with practical insights on patient selection, sequencing, and toxicity management from the RAMP-201 study.

Description

Rachel Grisham presents long-term safety and efficacy data for Avutometinib + Defactinib in recurrent low-grade serous ovarian cancer, based on findings from the RAMP-201 study presented at the SGO 2026 annual meeting. Discussing long-term follow-up data from the study, highlighting the durable efficacy and manageable safety profile of Avutometinib + Defactinib in recurrent low-grade serous ovarian cancer, with practical insights on patient selection, biomarker testing, sequencing, and toxicity management.

Presented by:

Rachel N. Grisham, MD
Section Head, Ovarian Cancer
Director, Gynecologic Medical Oncology, MSK Westchester
Memorial Sloan Kettering Cancer Center
USA

Moderated by:

	Wendel Naumann, MD Director of Minimally Invasive Surgery in Gynecologic Oncology Carolinas Medical Center Associate Medical Director of Clinical Trials Levine Cancer Institute, Atrium Health USA
	Floor Backes, MD The Ohio State University Wexner Medical Center James Comprehensive Cancer Center USA

Attended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.

Supported in part by

Summary

Availability:

On-Demand

Cost:

FREE

Create Account

Recommended

From Data to Practice: Integrating Key Phase III Results into Ovarian Cancer Management

Kathleen Moore details outcome measures from three major phase III trials—KEYNOTE-B96, ROSELLA, and MIRASOL—highlighting objective response rates, progression-free and overall survival, and key safety signals.

Free

Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications

This course offers an in-depth exploration of personalized treatment approaches for endometrial cancers, focusing on proficient mismatch repair (pMMR), deficient mismatch repair (dMMR) diseases and molecular classification in the recurrent setting.

Free

Redefining Platinum Sensitivity : Additional Treatment Considerations in a Changing Paradigm

Dr. Robert Coleman with moderation by Dr. Floor Backes and Dr. Wendel Naumman. Dr. Coleman explores the evolving treatment strategies for recurrent platinum-sensitive ovarian cancer, drawing on the latest clinical trial data and real-world outcomes.

Free

IGCS 2024 Cervical Master Sessions: Moving Forwards

Held at the IGCS 2024 Annual Global Meeting in Dublin, Ireland on October 16, 2024.

Free

Precision in Endometrial Cancer: Personalized Treatment Strategies for pMMR and dMMR Endometrial Cancer

This interactive 90-minute symposium will explore the evolving treatment landscape in endometrial cancer, focusing on the distinctions between dMMR and pMMR disease.

Free

IGCS 2024 Endometrial Cancer Master Session

Held at the IGCS 2024 Annual Global Meeting in Dublin, Ireland on October 16, 2024.

Free

Challenging Gynecologic Oncology Surgery - Surgical Film Festival

Surgical Film Festival held on January 12, 2024.

$0.00 - $50.00

Surgical Film Library

Curated film collection reviewed by global surgical experts showcasing gynecologic oncology surgery procedures and techniques. Films provide practical learning through surgical demonstrations.

Free

2025 IGCS-IGCAN Gynecologic Cancer Survivor-Caregiver Summit

Free

Malignant Bowel Obstruction in Gynecologic Cancers Podcast Series

This podcast series explores the complexities of malignant bowel obstruction (MBO) in gynecologic cancer patients, offering expert insights into diagnosis, decision-making, ethics, surgical and non-surgical management strategies, and future directions in care.

Free